Company Active PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Company profile

Macmillan Cancer Support

UK company 02400969, incorporated on 30 June 1989.

My Care Plan

Macmillan Cancer Support is a UK company with status active founded in 1989 based in London.

Company number

02400969

Incorporated

30 Jun 1989

Companies House status

Active

Company identity

Founded / incorporated

30 June 1989

Company number 02400969

Verify at Companies House

Legal name

MACMILLAN CANCER SUPPORT

Company type

PRIVATE-LIMITED-GUARANT-NSC-LIMITED-EXEMPTION

Region

London

Registered address

Unknown

Insolvency history

Corporate ownership

Updated 07 Jul 2026 09:49

Controls 3

Macmillan Cancer Support

No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

2 events

22 Sep

2026

Accounts With Accounts Type Group

Accounts PDF pending

AA | Transaction MzU0NjAxMTg3MGFkaXF6a2N4 | Paper/PDF filed

Published 22 Sep 2026 22:58

30 Jun

1989

Incorporated

Inception

Company registered at Companies House

Public funding

1 award

First funded

2023

Funded years

2023

Age at first award

33 years

Projects

2023 Collaborative R&D

Development of the NeutroCheck diagnostic device to enable remote triage of chemotherapy patients at risk of neutropenic sepsis

1 Jan 2023 to 30 Sep 2024

Awarded

£23,818

Total cost £23,818

Neutropenic sepsis (NS) is a life-threatening complication of cancer chemotherapy. It occurs because chemotherapy temporarily suppresses the immune system, particularly neutrophil cells, and even mild illnesses can be fatal for patients during this time. As a result, if any chemotherapy patient has a fever or feels unwell they are advised to attend hospit...

Product types

Collaborative R&D